Abrocitinib 100 mg versus 200 mg for atopic dermatitis:
a meta-analysis of randomized controlled trials

Abrocitinib 100 mg versus 200 mg for atopic dermatitis: a meta-analysis of randomized controlled trials

Bibliographic Details
Main Authors:	Junqiao Wang, Yuanjuan Yang, Haitao Yang, Xiaojuan Fu
Format:	Article
Language:	English
Published:	Termedia Publishing House 2022-03-01
Series:	Advances in Dermatology and Allergology
Subjects:	abrocitinib 100 mg 200 mg atopic dermatitis randomized controlled trials
Online Access:	https://www.termedia.pl/Abrocitinib-100-mg-versus-200-mg-for-atopic-dermatitis-r-na-meta-analysis-of-randomized-controlled-trials,7,46722,1,1.html

Similar Items

Efficacy of abrocitinib for atopic dermatitis: a meta-analysis of randomized controlled trials
by: Daojun Zhang, et al.
Published: (2021-10-01)

Research progress on abrocitinib in the treatment of moderate and severe atopic dermatitis
by: Xu ZHU, et al.
Published: (2023-08-01)

Efficacy and Safety of JAK1 Inhibitor Abrocitinib in Atopic Dermatitis
by: Helena Iznardo, et al.
Published: (2023-01-01)

Efficacy and safety of abrocitinib for moderate-to-severe atopic dermatitis in adolescents and adults: Meta-analysis
by: Ling Li, et al.
Published: (2023-05-01)

The Efficacy and Safety of Abrocitinib as a Treatment Option for Atopic Dermatitis: A Short Report of the Clinical Data
by: Napolitano M, et al.
Published: (2021-03-01)

Efficacy and safety of abrocitinib and upadacitinib versus dupilumab in adults with moderate-to-severe atopic dermatitis: A systematic review and meta-analysis
by: Qin Gao, et al.
Published: (2023-06-01)

Unveiling abrocitinib: A thorough examination of the 2022 USFDA-approved treatment for atopic dermatitis (AD)
by: Daniela Bermeo Grajales, et al.
Published: (2023-12-01)

Efficacy and safety of abrocitinib monotherapy in adolescents and adults: a post hoc analysis of the phase 3 JAK1 atopic dermatitis efficacy and safety (JADE) REGIMEN clinical trial
by: Carsten Flohr, et al.
Published: (2023-12-01)

Once-Daily Abrocitinib for the Treatment of Moderate-to-Severe Atopic Dermatitis in Adults and Adolescents Aged 12 Years and Over: A Short Review of Current Clinical Perspectives
by: Niculet E, et al.
Published: (2022-04-01)

Successful Treatment of Atopic Dermatitis with a Predominant Nipple Involvement by Abrocitinib During COVID-19 Pandemic: A Case Report
by: Teng Y, et al.
Published: (2023-08-01)

A Case of Perioral Dermatitis Successfully Treated with Abrocitinib
by: Teng Y, et al.
Published: (2023-10-01)

Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice
by: Melinda J. Gooderham, et al.
Published: (2023-07-01)

Real-world Experience of Abrocitinib Treatment in Patients with Atopic Dermatitis and Hand Eczema: Up to 28-week Results from the BioDay Registry
by: Esmé Kamphuis, et al.
Published: (2024-02-01)

Economic impact of abrocitinib monotherapy and combination therapy in patients with moderate-to-severe atopic dermatitis: Results from JADE MONO-2 and JADE COMPARE
by: Melinda J. Gooderham, MSc, MD, FRCPC, et al.
Published: (2021-09-01)

Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib
by: Novin Nezamololama, et al.
Published: (2020-11-01)

Efficacy and safety of abrocitinib for the treatment of moderate-to-severe atopic dermatitis: a meta-analysis of randomized clinical trials
by: Bikash Ranjan Meher, et al.
Published: (2022-05-01)

JAK-STAT Inhibitors in Atopic Dermatitis from Pathogenesis to Clinical Trials Results
by: Krzysztof Szalus, et al.
Published: (2020-11-01)

S100 Proteins in the Pathogenesis of Psoriasis and Atopic Dermatitis
by: Natsuko Saito-Sasaki, et al.
Published: (2023-10-01)

Effect of abrocitinib and dupilumab on eosinophil levels in patients with moderate‐to‐severe atopic dermatitis
by: Delphine Staumont‐Sallé, et al.
Published: (2023-09-01)

Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
by: Michelle Le, et al.
Published: (2021-09-01)

Abrocitinib as a Novel Treatment for Multiple Skin Disorders: 3 Case Reports and a Scoping Review
by: Chen P, et al.
Published: (2024-01-01)

Systematic review and network meta-analysis of the risk of Herpes zoster with biological therapies and selective Janus kinase-1 inhibitors in atopic dermatitis
by: Daud Manzar, et al.
Published: (2024-03-01)

Abrocitinib, tralokinumab and upadacitinib for treating moderate-to-severe atopic dermatitis
by: Steven J Edwards, et al.
Published: (2024-01-01)

A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
by: Jiahui Zhao, PhD, MD, et al.
Published: (2022-04-01)

Is Dupilumab as Effective in Intrinsic Atopic Dermatitis as It Is in Extrinsic Atopic Dermatitis?
by: Federica Gelato, et al.
Published: (2023-03-01)

Abrocitinib monotherapy in Investigator’s Global Assessment nonresponders: improvement in signs and symptoms of atopic dermatitis and quality of life
by: Andrew Blauvelt, et al.
Published: (2022-07-01)

Oral abrocitinib in the treatment of granuloma annulare: a case report
by: Wenyan Liu, et al.
Published: (2024-12-01)

Successful treatment of refractory prurigo nodularis with abrocitinib
by: Fang Sun, et al.
Published: (2024-03-01)

Topical application of Jaungo in atopic dermatitis patients: study protocol for a randomized, controlled trial
by: Younghee Yun, et al.
Published: (2017-04-01)

Successful Treatment of Granulomatous Rosacea by JAK Inhibitor Abrocitinib: A Case Report
by: Ren M, et al.
Published: (2023-11-01)

Efficacy of baricitinib 4 mg in patients with moderate‐to‐severe atopic dermatitis previously treated with systemic therapy
by: Antonio Costanzo, et al.
Published: (2023-09-01)

Formulation of Budesonide-Loaded Polymeric Nanoparticles into Hydrogels for Local Therapy of Atopic Dermatitis
by: Marta Slavkova, et al.
Published: (2024-01-01)

Real-Time Experience of Abrocitinib for the Treatment of Mucous Membrane Pemphigoid: A Case Report
by: Teng Y, et al.
Published: (2024-02-01)

Allergic contact dermatitis masquerading as atopic dermatitis
by: Sarah Semaan, BS, et al.
Published: (2020-09-01)

Catalytic Performance of CPM-200-In/Mg in the Cycloaddition of CO<sub>2</sub> and Epoxides
by: Yunjang Gu, et al.
Published: (2021-03-01)

Probiotics for the prevention of atopic dermatitis in infants from different geographic regions: a systematic review and Meta-analysis
by: Lifeng Chen, et al.
Published: (2022-10-01)

Tuning Epitaxial Growth of Nb on MgO(100)
by: Laura Guasco, et al.
Published: (2023-06-01)

Evaluation of Leukocytes, B and T Lymphocytes, and expression of CD200 and CD23 on B lymphocytes in Patients with Atopic Dermatitis on Dupilumab Therapy—Pilot Study
by: Jarmila Čelakovská, et al.
Published: (2023-04-01)

Prevention of Atopic Dermatitis
by: Hywel C. Williams, et al.
Published: (2020-06-01)

Guidelines for treatment of atopic dermatitis
by: Suzana Ljubojević Hadžavdić, et al.
Published: (2022-10-01)